Soft tissue sarcomas: introduction to the Virchows Archiv review issue

od Guillou, Louis, Hogendoorn, Pancras C. W., Bosman, Fred T.
Izdano 2010

Soft Tissue Tumours of the Retroperitoneum

od Van Roggen, J. Frans Graadt, Hogendoorn, Pancras C. W.
Izdano 2000

Molecular pathology of sarcomas: concepts and clinical implications

od Bovée, Judith V. M. G., Hogendoorn, Pancras C. W.
Izdano 2009

Sequencing Overview of Ewing Sarcoma: A Journey across Genomic, Epigenomic and Transcriptomic Landscapes

od Sand, Laurens G. L., Szuhai, Karoly, Hogendoorn, Pancras C. W.
Izdano u Int J Mol Sci (2015)

Osteosarcoma Models: From Cell Lines to Zebrafish

od Mohseny, Alexander B., Hogendoorn, Pancras C. W., Cleton-Jansen, Anne-Marie
Izdano 2012

Expression of CCL21 in Ewing sarcoma shows an inverse correlation with metastases and is a candidate target for immunotherapy

od Sand, Laurens G. L., Berghuis, Dagmar, Szuhai, Karoly, Hogendoorn, Pancras C. W.
Izdano u Cancer Immunol Immunother (2016)

The molecular and cellular basis of exostosis formation in hereditary multiple exostoses

od Reijnders, Christianne M A, Hogendoorn, Pancras C W, Bovée, Judith V M G
Izdano 2009

Mesenchymal stem cell transformation and sarcoma genesis

od Xiao, Wei, Mohseny, Alexander B, Hogendoorn, Pancras C W, Cleton-Jansen, Anne-Marie
Izdano 2013

Mutation-driven epigenetic alterations as a defining hallmark of central cartilaginous tumours, giant cell tumour of bone and chondroblastoma

od Venneker, Sanne, Szuhai, Karoly, Hogendoorn, Pancras C. W., Bovée, Judith V. M. G.
Izdano u Virchows Arch (2019)

Running GAGs: myxoid matrix in tumor pathology revisited: What’s in it for the pathologist?

od Willems, Stefan M., Wiweger, Malgorzata, van Roggen, J. Frans Graadt, Hogendoorn, Pancras C. W.
Izdano 2009

Imatinib Mesylate in Patients with WHO B3 Thymomas and Thymic Carcinomas

od Giaccone, Giuseppe, Rajan, Arun, Ruijter, Rita, Smit, Egbert, van Groeningen, Cees, Hogendoorn, Pancras C. W.
Izdano u J Thorac Oncol (2009)

HSPG-Deficient Zebrafish Uncovers Dental Aspect of Multiple Osteochondromas

od Wiweger, Malgorzata I., Zhao, Zhe, van Merkesteyn, Richard J. P., Roehl, Henry H., Hogendoorn, Pancras C. W.
Izdano 2012

Possible effects of EXT2 on mesenchymal differentiation - lessons from the zebrafish

od Wiweger, Malgorzata I, de Andrea, Carlos E, Scheepstra, Karel W F, Zhao, Zhe, Hogendoorn, Pancras C W
Izdano 2014

Peripheral chondrosarcoma progression is associated with increased type X collagen and vascularisation

od de Andrea, Carlos E., Wiweger, Malgorzata I., Bovée, Judith V. M. G., Romeo, Salvatore, Hogendoorn, Pancras C. W.
Izdano 2011

Co-existence of lung carcinoma metastasis and enchondroma in the femur of a patient with Ollier disease

od Wang, Xudong, Zhang, Xiaohui, Pan, Wenling, Han, Yuedong, Li, Yanwei, Sun, Haibin, Hogendoorn, Pancras C. W., Cheng, Hong
Izdano u Virchows Arch (2020)

Aberrant Chemokine Receptor Expression and Chemokine Production by Langerhans Cells Underlies the Pathogenesis of Langerhans Cell Histiocytosis

od Annels, Nicola E., da Costa, Cristiana E.T., Prins, Frans A., Willemze, Annemieke, Hogendoorn, Pancras C.W., Egeler, R. Maarten
Izdano 2003

Method to measure the mismatch between target and achieved received dose intensity of chemotherapy in cancer trials: a retrospective analysis of the MRC BO06 trial in osteosarcoma

od Lancia, Carlo, Anninga, Jakob, Spitoni, Cristian, Sydes, Matthew R., Whelan, Jeremy, Hogendoorn, Pancras C W, Gelderblom, Hans, Fiocco, Marta
Izdano u BMJ Open (2019)

Neoadjuvant denosumab for extensive giant cell tumor in os ischium —a case report

od van der Heijden, Lizz, van de Sande, Michiel A J, Hogendoorn, Pancras C W, Gelderblom, Hans, Dijkstra, P D Sander
Izdano u Acta Orthop (2015)

A novel method to address the association between received dose intensity and survival outcome: benefits of approaching treatment intensification at a more individualised level in...

od Lancia, Carlo, Anninga, Jakob K., Sydes, Matthew R., Spitoni, Cristian, Whelan, Jeremy, Hogendoorn, Pancras C. W., Gelderblom, Hans, Fiocco, Marta
Izdano u Cancer Chemother Pharmacol (2019)

Adjuvant Zoledronic Acid in High‐Risk Giant Cell Tumor of Bone: A Multicenter Randomized Phase II Trial

od Lipplaa, Astrid, Kroep, Judith R., van der Heijden, Lizz, Jutte, Paul C., Hogendoorn, Pancras C.W., Dijkstra, Sander, Gelderblom, Hans
Izdano u Oncologist (2019)